A potential tumor suppressor role of PLK2 in glioblastoma

Xiangping Xia1,2, Peirui Wang2, Hua Xiao2

  • 1Soochow University Medical College, Suzhou, China.

FEBS Open Bio
|February 10, 2025
PubMed

Insights

Polo-like kinase 2 (PLK2) is downregulated in glioblastoma (GBM). Overexpressing PLK2 suppressed GBM tumor growth, offering a potential new therapeutic strategy for this aggressive brain cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Glioblastoma (GBM) is an aggressive brain tumor with poor prognosis.
  • The role of Polo-like kinase 2 (PLK2) in GBM pathogenesis is not well understood.
  • Limited therapeutic options exist for GBM patients.

Purpose of the Study:

  • To investigate the expression and function of PLK2 in glioblastoma.
  • To determine the potential of PLK2 as a therapeutic target for GBM.

Main Methods:

  • Analysis of RNA-seq data from GEO, TCGA, and CGGA databases.
  • Experiments on human U87MG and U251 GBM cell lines.
  • In vivo evaluation of PLK2's tumorigenic potential in a mouse model.

Main Results:

  • PLK2 expression was consistently downregulated in GBM tissues compared to normal brain.
  • Overexpression of PLK2 in GBM cells reduced viability, proliferation, and migration.
  • PLK2 overexpression induced cell cycle arrest and enhanced apoptosis in GBM cells.

Conclusions:

  • PLK2 acts as a tumor suppressor in glioblastoma.
  • Therapeutic strategies involving PLK2 overexpression may inhibit GBM progression.
  • PLK2 represents a potential novel therapeutic target for glioblastoma treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K